直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Webinar

Patenting AI Inventions for the Healthcare and Pharmaceutical Industries

April 7, 2021

Webinar

View Webinar

From rapid drug discovery to smart medical devices and robotic surgery, artificial intelligence (AI) is a driving force of innovation and change in the healthcare and pharmaceutical industries. As the influence and value of this technology grows, so too does the importance of developing effective patent strategies for AI inventions. This webinar will address the key questions faced by innovators in this space, including the best strategies and considerations for protecting AI-implemented inventions for healthcare products and services, and how to navigate legal issues and challenges such as those related to inventorship, patentability, and disclosure requirements.

Topics to be discussed include:

  • Critical issues surrounding the protection of AI technology
  • What can be protected in the U.S. and Europe
  • Patent and claim drafting strategies with an eye towards enforcement
  • Applicable guidance from the USPTO and EPO
  • Key takeaways for patenting AI inventions for the healthcare and pharmaceutical industries

 

Recorded: View On Demand

Speakers:
Charles Collins-Chase
Luigi Distefano
C. Gregory Gramenopoulos

Tags

AI + Patent

Related Practices

Global IP Enforcement, Litigation, and Trials

Related Industries

AI, Electronics, and Information Technology

Robotics

Artificial Intelligence (AI) and Machine Learning (ML)

Life Sciences

Pharmaceutical

Medical Device and Diagnostics

Digital Health

Biologics

Related Professionals

Charles T. Collins-Chase
Partner
Washington, DC
+1 202 408 4108
Email
C. Gregory Gramenopoulos
Partner
Washington, DC
+1 202 408 4263
Email
Luigi Distefano
Partner
London
+44 (0)20 7864 2800
Email

Related Insights

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Lecture

Resolving Patent Suits Without Settlement Payments

September 3, 2026

Virtual

Webinar

U.S. Patent Case Law Update 2026

July 23, 2026

Webinar

Conference

2026 China Pharmaceutical Innovation Conference

July 22-24, 2026

Shanghai

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

Webinar

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: May 2026

June 30, 2026

Articles

How Low Can You Go? Courts Lower Marking Defense Burden, Raising Patent Damages Risks

June 29, 2026

Federal Circuit IP Blog

Mere Invalidity of Asserted Claims Does Not Render Patent Infringement Case Exceptional or Warrant Sanctions

June 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP